ALBIOBiosynex SA
0.9200EUR0.00%Mkt Cap: 18.43M $P/E:

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immun…

Key Statistics

Company
Market Cap18.43M $
Enterprise Value76.65M $
Revenue (TTM)103.47M $
Gross Profit56.91M $
Net Income (TTM)-63.29M $
Revenue/Share5.614 USD
Last Price0.9200 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees397
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011005933
Valuation
P/E (Trailing)
P/E (Forward)2.04
PEG
EV/EBITDA-5.17
EV/Revenue0.74
P/S0.18
P/B0.47
EPS (TTM)-4.03
EPS (Forward)0.46
52W Range
0.455042% of range1.570
52W High1.570 EUR
52W Low0.4550 EUR
Profitability
Gross Margin55.00%
Oper. Margin17.37%
EBITDA Margin-14.33%
Profit Margin-61.16%
ROE-166.59%
ROA-42.74%
Growth
Revenue Growth-5.80%
Earnings Growth
Cash Flow & Leverage
Operating CF-6.40M $
CapEx (TTM)2.92M $
FCF Margin14.89%
FCF Yield83.58%
Net Debt57.82M $
Net Debt/EBITDA-3.90
Balance Sheet
Debt/Equity1.76
Current Ratio0.64
Quick Ratio0.33
Book Value/Sh2.001 EUR
Cash/Share0.4590 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateMay 16, 2022
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.18.43M
Float7.78M
Insiders57.60%
Institutions0.00%
Technical
SMA 500.9141 (+0.6%)
SMA 2000.8326 (+10.5%)
Beta0.83
S&P 52W Chg18.16%
Avg Vol (30d)12.09K
Avg Vol (10d)27.20K
Technical Indicators
RSI (14)49.1
MACD0.0033
MACD Signal0.0028
MACD Hist.+0.0005
BB Upper0.9722 EUR
BB Middle0.9250 EUR
BB Lower0.8778 EUR
BB Width10.21%
ATR (14)0.0312 EUR
Vol Ratio (20d)0.72x